| Medical and Health Sciences | Lifetime | 318 | GB 36 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 592 | GB 56 | 99.87 |
| Pulmonary and Respiratory Medicine | Lifetime | 61 | GB 6 | 99.92 |
| Clinical Neurology | Lifetime | 45 | GB 10 | 99.85 |
| Epidemiology | Lifetime | 191 | GB 14 | 99.76 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 464 | GB 39 | 98.85 |
| Cardiology and Cardiovascular Medicine | Lifetime | 625 | GB 42 | 98.95 |
| Neuroscience of Neurology | Lifetime | 258 | GB 17 | 97.99 |
| Rheumatology | Lifetime | 694 | GB 64 | 96.49 |
| Rehabilitation | Lifetime | 747 | GB 89 | 83.87 |
| Clinical Neurology | 2021-2025 | 11 | GB 1 | 99.65 |
| Neuroscience of Neurology | 2021-2025 | 26 | GB 2 | 98.52 |
| Epidemiology | 2021-2025 | 169 | GB 16 | 98.87 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 742 | GB 44 | 90.61 |
| Rehabilitation | 2021-2025 | 151 | GB 12 | 85.54 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 724 | GB 50 | 83.09 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 5 | GB 3 | 99.96 |
| Acute Ischemic Stroke Management | Lifetime | 9 | GB 4 | 99.94 |
| Cardiovascular Health and Disease Prevention | Lifetime | 16 | GB 4 | 99.83 |
| Cerebrovascular and genetic disorders | Lifetime | 3 | GB 1 | 99.75 |
| Moyamoya disease diagnosis and treatment | Lifetime | 5 | GB 1 | 99.67 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 30 | GB 5 | 99.73 |
| Intracranial Aneurysms: Treatment and Complications | Lifetime | 56 | GB 3 | 99.61 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 35 | GB 4 | 99.54 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 66 | GB 7 | 99.23 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 370 | GB 26 | 98.81 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 269 | GB 39 | 98.79 |
| Genetic Associations and Epidemiology | Lifetime | 227 | GB 44 | 98.72 |
| Dementia and Cognitive Impairment Research | Lifetime | 434 | GB 50 | 98.64 |
| Advanced MRI Techniques and Applications | Lifetime | 878 | GB 99 | 98.08 |
| Stroke Rehabilitation and Recovery | Lifetime | 722 | GB 68 | 97.50 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 644 | GB 43 | 97.21 |
| Nuclear Receptors and Signaling | Lifetime | 256 | GB 22 | 96.22 |
| Renin-Angiotensin System Studies | Lifetime | 399 | GB 25 | 96.41 |
| Metalloenzymes and iron-sulfur proteins | Lifetime | 1,000 | GB 79 | 87.22 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 2 | GB 1 | 99.58 |
| Acute Ischemic Stroke Management | 2021-2025 | 22 | GB 3 | 99.65 |
| Cerebrovascular and genetic disorders | 2021-2025 | 1 | GB 1 | 99.48 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 8 | GB 3 | 99.51 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 43 | GB 2 | 99.28 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 313 | GB 23 | 97.23 |
| Moyamoya disease diagnosis and treatment | 2021-2025 | 43 | GB 1 | 94.06 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 408 | GB 31 | 93.50 |
| Stroke Rehabilitation and Recovery | 2021-2025 | 684 | GB 33 | 91.96 |
| Cerebrospinal fluid and hydrocephalus | 2021-2025 | 402 | GB 18 | 87.66 |
| Genetic Associations and Epidemiology | 2021-2025 | 823 | GB 137 | 87.42 |
| Intracranial Aneurysms: Treatment and Complications | 2021-2025 | 762 | GB 9 | 88.64 |
| Cell Adhesion Molecules Research | 2021-2025 | 329 | GB 21 | 81.82 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 354 | GB 10 | 78.72 |
| Metalloenzymes and iron-sulfur proteins | 2021-2025 | 236 | GB 13 | 73.78 |
| Neurological diseases and metabolism | 2021-2025 | 667 | GB 70 | 64.89 |
